510(k) Report

FDA applicant

Cardioline S.P.A

Cavareno, TN4 decisions2015–20231 recall

FDA records 4 decisions for Cardioline S.P.A (Cavareno, TN) from 2015 to 2023: 4 510(k) clearances. Most are in product codes DRG (Transmitters And Receivers, Physiological…) and DPS (Electrocardiograph). Since 2016 its 510(k)s took a median of 229 days from receipt to decision, against 229 for FDA’s reviews in the same codes and years. Its devices cite 7 predicates, 1 of them its own earlier devices. 1 recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Cardioline S.P.A’s devices, and how often a recall has named them.

FDA decisions per year

1in 2023

2015: 12016: 22023: 1
2015high 2 (2016) · low 0 (2017)2026

2026 so far, outlined.

Recalls per year

1in 2026

2026 (partial year): 1
2015high 1 (2026) · low 0 (2015)2026

Class I Class II/III not classified

FIG. 1 — Cardioline S.P.A by year, 2015–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Cardioline S.P.A’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report